Drug Trial Radar · NCT03960580
Study Evaluating the Efficacy and Safety of Intranasal Administration of OPN-375 in Subjects With Chronic Rhinosinusitis Without the Presence of Nasal Polyps
Last checked: Nov 19, 2026Latest source record: Dec 21, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
223
Actual
Start
Jun 6, 2019
Primary completion
May 4, 2022
Study completion May 4, 2022
Sponsor
- Lead sponsor
- Optinose US Inc.Industry
- Sponsor type
- Industry
- First posted
- May 23, 2019
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a 24-week randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate the efficacy and safety of intranasal administration of 186 and 372 μg twice daily (BID) of OPN-375 in subjects with chronic Rhinosinusitis (CRS) without nasal polyps
Conditions
- Chronic Rhinosinusitis
Interventions
OPN-375Drug
OPN-375, BID
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Symptoms as Measured by a Composite Score for Each Symptom of Nasal Congestion, Facial Pain or Pressure Sensation, and Nasal Discharge (Anterior and/or Posterior) at the End of Week 4Time frame: 4 Weeks
- Change From Baseline to Week 24/Early Termination (ET) in the Average Percent of the Volume Opacified (APOV) in the Ethmoid and Maxillary Sinuses.Time frame: Baseline, Week 24
Locations
87 sites in 10 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama
Sacramento Ear, Nose & Throat Surgical and Medical Group Inc
Folsom, California
BioSolutions Clinical Research Center
La Mesa, California
Veterans Administration Greater Los Angeles Healthcare System
Los Angeles, California
Sacramento Ear, Nose & Throat Surgical and Medical Group
Roseville, California
Asthma and Allergy Associates
Colorado Springs, Colorado
Sher Allergy Specialists
Largo, Florida
University of Miami Miller School of Medicine
Miami, Florida
Treasure Valley Medical Research
Boise, Idaho
Best Clinical Trials
New Orleans, Louisiana
University of Missouri, Dept of Otorlaryngology
Columbia, Missouri
Mount Sinai Downtown Union Square
New York, New York
Northwell Health at ENT and Allergy Associates
New York, New York
Charlotte Eye Ear Nose and Throat Assoc., PA
Matthews, North Carolina
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania
ENT & Allergy Partners, LLC
Summerville, South Carolina
Pasha Snoring & Sinus Center
Houston, Texas
University of Utah
Salt Lake City, Utah
Eastern Virginia Medical School
Norfolk, Virginia
Allergy, Asthma & Sinus Center, SC
Greenfield, Wisconsin
Otopure Pty Ltd
Bella Vista, New South Wales, Australia
Vale Medical Practice
Brookvale, New South Wales, Australia
Australian Clinical Research Network
Maroubra, New South Wales, Australia
Browns Plains Family Practice
Browns Plains, Queensland, Australia
Casey Superclinic
Berwick, Victoria, Australia
Camberwell Road Medical Practice
Hawthorn East, Victoria, Australia
Mirrabooka Medical Centre
Mirrabooka, Western Australia, Australia
Latitude Clinical Research
Spearwood, Western Australia, Australia
UMHAT Kaspela EOOD
Plovdiv, Bulgaria
Medical Center Iskar EOOD
Sofia, Bulgaria
MHAT Serdika EOOD
Sofia, Bulgaria
MC N.I. Pirogov EOOD
Sofia, Bulgaria
MHAT - Central Clinical Base Sofia Medical Institute Ministry of Interior
Sofia, Bulgaria
MMA MHAT - Sofia
Sofia, Bulgaria
DCC Convex EOOD
Sofia, Bulgaria
MHAT Trakiya EOOD
Stara Zagora, Bulgaria
DCC "Mladost - M Varna" OOD
Varna, Bulgaria
Nemocnice Rudolfa a Stefanie Benesov, a.s., ORL oddeleni
Benešov, Czechia
FN Hradec Kralove, Klinika ORL
Hradec Králové, Czechia
Pro-audio s.r.o.
Mladá Boleslav, Czechia
Showing 40 of 87 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.